KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02
Eden Scientific: 16 Kovera certificates.
The lab's record shows 16 certificates printed for Eden Scientific, analysed between 11 Feb 2026 and 26 Apr 2026, covering 14 products. Median HPLC purity is 99.95%. Kovera graded 16 as a pass and 0 as a fail.
16
certificates
99.95%
median purity
14
products
0
lab verdict: fail
0
failure rules met
What the record shows
RETRIEVED 2 AUGUST 2026None of the 16 certificates meets our failure rules: no lab fail, no unconfirmed identity, no purity under 95% and no content under 90% of the label. 10 measured more than 110% of the label, which Kovera does not grade as a fail.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
14 AS PRINTEDBPC-157 · 2R3 · 2Cagrilintide · 1GHK-Cu · 1KPV · 1MOTS-c · 1Retatrutide · 1Selank · 1Semax · 1SS-31 · 1TB-500 (Thymosin B4) · 1Tesamorelin · 1Thymosin alpha-1 · 1Tirzepatide · 1
Every certificate
NEWEST FIRST · 16 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| KVR-2026-63F4B8 | BPC-157 | ES-BC-10-LX1 | 99.878% | 97.3%9.73 of 10 mg | 26 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-20A6AF | Thymosin alpha-1 | ES-TA-10-LX1 | 99.858% | 113.2%11.32 of 10 mg | 26 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-D04A1F | Semax | ES-SX-10-Z1 | 99.898% | 106.9%10.69 of 10 mg | 20 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-5D21DA | R3 | ES-R3-30-LX1 | 99.858% | 112.8%33.83 of 30 mg | 20 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-4D3344 | R3 | ES-R3-30-Z1 | 99.871% | 118.4%35.51 of 30 mg | 20 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-677642 | Tesamorelin | ES-TS-10-B1 | 99.959% | 110.9%11.09 of 10 mg | 5 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-26A877 | Selank | ES-SK-10-V1 | 99.943% | 116.7%11.67 of 10 mg | 4 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-D16EA5 | KPV | ES-KPV-10-B1 | 99.971% | 108.4%10.84 of 10 mg | 28 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-53D383 | MOTS-c | ES-MS-40-B1 | 99.946% | 112.3%44.92 of 40 mg | 28 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-4C9978 | Tirzepatide | ES-T2-60-B1 | 99.946% | 109.8%65.91 of 60 mg | 28 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-1E6924 | GHK-Cu | ES-CU-100-BV2 | 99.947% | 115.7%115.69 of 100 mg | 28 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-E01AE4 | Retatrutide | ES-R3-30-CL1 | 99.976% | 110.6%33.19 of 30 mg | 22 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-CCB7B4 | BPC-157 | ES-BC10-B1WD | 99.972% | 117.4%11.74 of 10 mg | 22 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-AB9348 | Cagrilintide | ES-CAG-10-CL1 | 99.923% | 108.1%10.81 of 10 mg | 22 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-0D266E | TB-500 (Thymosin B4) | ES-TB-10-CL1 | 99.946% | 115.1%11.51 of 10 mg | 22 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-8D12AD | SS-31addon only certificate | ES2S3450B1 | 99.984% | — | 11 Feb 2026 | PASS | Kovera ↗our verifier → |